Vyvanse: Many Advantages as ADHD Therapy?

Vyvanse: Many Advantages as ADHD Therapy?

Vyvanse is a new treatment for ADHD that is very promising.  Importantly, it has several advantages that distinguish it from the many competing treatments.  At Health and Life, we are skeptical by nature, but there are advantages to Vyvanse that make it stand out. In...
The New Medications in 2010 – Highlights

The New Medications in 2010 – Highlights

As someone who spends a fair bit of time thinking about and dealing with medications and treatments, I like to think I know a little about the subject.  And, to be honest, I was getting a little concerned.  It seemed like there was a real lack of innovative therapies...
Qnexa for Weight Loss; Side Effects

Qnexa for Weight Loss; Side Effects

Qnexa is a new medication that will go for FDA approval in 2010 and is a treatment for obesity.  It consists of phentermine and topiramate and has shown excellent results in studies to date.  Concerns, however, remain about its safety and long run effectiveness....
The Weekly Pharma News Update #6

The Weekly Pharma News Update #6

It’s Sunday – and that means another Weekly Pharma News Update from Health and Life.  What were the most interesting and important news items of the last week regarding the biopharmaceutical industry? #1 Nobel Prize-winning scientist Sir James Black dies...
The Weekly Pharma News Update #5

The Weekly Pharma News Update #5

Another Sunday, another Pharma news update from Health and Life.  What were the biggest news items of the last week and what might they mean? #1 Diabetes Heart Treatments May Cause Harm Recent data indicates that aggressive control of diabetic patients markers related...
The Very Best Pharma Blogs & Resources

The Very Best Pharma Blogs & Resources

There is a lot going on in the world of Pharmaceuticals.  Drugs are being discovered, being marketed, and, far too often it seems, being recalled. How much will a new medication sell?  Will it make through the clinical trials without being thrown out for lack of...